Skip to main content
Top
Published in: Critical Care 2/2013

01-04-2013 | Review

Renal oxygenation in clinical acute kidney injury

Authors: Sven-Erik Ricksten, Gudrun Bragadottir, Bengt Redfors

Published in: Critical Care | Issue 2/2013

Login to get access

Excerpt

Renal oxygenation is defined as the relationship between renal oxygen delivery (DO2) and renal oxygen consumption (VO2) and it can easily be shown that the inverse of this relationship is equivalent to renal extraction of O2 (O2Ex). An increase in renal O2Ex means that renal DO2 has decreased in relation to renal VO2, i. e., renal oxygenation is impaired, and vice versa. When compared to other major organs, renal VO2 is relatively high, second only to the heart. In sedated, mechanically ventilated patients, renal VO2 is two-thirds (10 ml/min) that of myocardial oxygen consumption (15 ml/min) (Table 1) [1, 2]. Renal blood flow, which accounts for approximately 20% of cardiac output, is three times higher than myocardial blood flow in this group of patients. Renal O2Ex in the non-failing kidney is therefore low, 10%, compared with, e.g., the heart, in which O2EX is 55% (Table 1).
Table 1
Renal and myocardial oxygen/demand supply relationship in postoperative mechanically ventilated patients
 
Kidney
Heart
Oxygen consumption (ml/min)
10
15
Blood flow (ml/min)
750
250
Oxygen extraction (%)
10
55
Appendix
Available only for authorised users
Literature
1.
go back to reference Zäll S, Milocco I, Ricksten SE: Effects of adenosine on myocardial blood flow and metabolism after coronary artery bypass surgery. Anesth Analg 1991, 73: 689-695.PubMed Zäll S, Milocco I, Ricksten SE: Effects of adenosine on myocardial blood flow and metabolism after coronary artery bypass surgery. Anesth Analg 1991, 73: 689-695.PubMed
2.
go back to reference Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten SE: Acute renal failure is NOT an "acute renal success" - a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med 2010, 38: 1695-1701. 10.1097/CCM.0b013e3181e61911CrossRefPubMed Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten SE: Acute renal failure is NOT an "acute renal success" - a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med 2010, 38: 1695-1701. 10.1097/CCM.0b013e3181e61911CrossRefPubMed
3.
go back to reference Kiil F, Aukland K, Refsum HE: Renal sodium transport and oxygen consumption. Am J Physiol 1961, 201: 511-516.PubMed Kiil F, Aukland K, Refsum HE: Renal sodium transport and oxygen consumption. Am J Physiol 1961, 201: 511-516.PubMed
4.
go back to reference Torelli G, Milla E, Faelli A, Costantini S: Energy requirement for sodium reabsorption in the in vivo rabbit kidney. Am J Physiol 1966, 211: 576-580.PubMed Torelli G, Milla E, Faelli A, Costantini S: Energy requirement for sodium reabsorption in the in vivo rabbit kidney. Am J Physiol 1966, 211: 576-580.PubMed
5.
go back to reference Swärd K, Valsson F, Sellgren J, Ricksten SE: Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2004, 31: 79-85.CrossRefPubMed Swärd K, Valsson F, Sellgren J, Ricksten SE: Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2004, 31: 79-85.CrossRefPubMed
6.
go back to reference Redfors B, Swärd K, Sellgren J, Ricksten SE: Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 2009, 35: 115-122. 10.1007/s00134-008-1206-5CrossRefPubMed Redfors B, Swärd K, Sellgren J, Ricksten SE: Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 2009, 35: 115-122. 10.1007/s00134-008-1206-5CrossRefPubMed
7.
go back to reference Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE: Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand 2009, 53: 1052-1059. 10.1111/j.1399-6576.2009.02037.xCrossRefPubMed Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE: Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand 2009, 53: 1052-1059. 10.1111/j.1399-6576.2009.02037.xCrossRefPubMed
8.
go back to reference O'Connor PM: Renal oxygen delivery: matching delivery to metabolic demand. Clin Exp Pharmacol Physiol 2006, 33: 961-967. 10.1111/j.1440-1681.2006.04475.xCrossRefPubMed O'Connor PM: Renal oxygen delivery: matching delivery to metabolic demand. Clin Exp Pharmacol Physiol 2006, 33: 961-967. 10.1111/j.1440-1681.2006.04475.xCrossRefPubMed
9.
go back to reference Levy MN: Effect of variations of blood flow on renal oxygen extraction. Am J Physiol 1960, 199: 13-18.PubMed Levy MN: Effect of variations of blood flow on renal oxygen extraction. Am J Physiol 1960, 199: 13-18.PubMed
10.
go back to reference Chou SY, Porush JG, Faubert PF: Renal medullary circulation: hormonal control. Kidney Int 1990, 37: 1-13. 10.1038/ki.1990.1CrossRefPubMed Chou SY, Porush JG, Faubert PF: Renal medullary circulation: hormonal control. Kidney Int 1990, 37: 1-13. 10.1038/ki.1990.1CrossRefPubMed
11.
go back to reference Brezis M, Rosen S: Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995, 332: 647-655. 10.1056/NEJM199503093321006CrossRefPubMed Brezis M, Rosen S: Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995, 332: 647-655. 10.1056/NEJM199503093321006CrossRefPubMed
12.
go back to reference Aukland K, Johannesen J, Kiil F: In vivo measurements of local metabolic rate in the dog kidney. Effect of mersalyl, chlorothiazide, ethacrynic acid and furosemide. Scand J Clin Lab Invest 1969, 23: 317-330. 10.3109/00365516909081697CrossRefPubMed Aukland K, Johannesen J, Kiil F: In vivo measurements of local metabolic rate in the dog kidney. Effect of mersalyl, chlorothiazide, ethacrynic acid and furosemide. Scand J Clin Lab Invest 1969, 23: 317-330. 10.3109/00365516909081697CrossRefPubMed
13.
go back to reference Kramer HJ, Schuurmann J, Wassermann C, Dusing R: Prostaglandin-independent protection by furosemide from oliguric ischaemic renal failure in conscious rats. Kidney Int 1980, 17: 455-464. 10.1038/ki.1980.53CrossRefPubMed Kramer HJ, Schuurmann J, Wassermann C, Dusing R: Prostaglandin-independent protection by furosemide from oliguric ischaemic renal failure in conscious rats. Kidney Int 1980, 17: 455-464. 10.1038/ki.1980.53CrossRefPubMed
14.
go back to reference Bayati A, Nygren K, Kallskog O, Wolgast M: The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand 1990, 139: 271-279. 10.1111/j.1748-1716.1990.tb08924.xCrossRefPubMed Bayati A, Nygren K, Kallskog O, Wolgast M: The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand 1990, 139: 271-279. 10.1111/j.1748-1716.1990.tb08924.xCrossRefPubMed
15.
go back to reference Shilliday I, Allison ME: Diuretics in acute renal failure. Ren Fail 1994, 16: 3-17. 10.3109/08860229409044843CrossRefPubMed Shilliday I, Allison ME: Diuretics in acute renal failure. Ren Fail 1994, 16: 3-17. 10.3109/08860229409044843CrossRefPubMed
16.
go back to reference Prasad PV, Edelman RR, Epstein FH: Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996, 94: 3271-3275. 10.1161/01.CIR.94.12.3271CrossRefPubMed Prasad PV, Edelman RR, Epstein FH: Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996, 94: 3271-3275. 10.1161/01.CIR.94.12.3271CrossRefPubMed
17.
go back to reference Cupples WA, Braam B: Assessment of renal autoregulation. Am J Physiol Renal Physiol 2007, 292: F1105-F11223.CrossRefPubMed Cupples WA, Braam B: Assessment of renal autoregulation. Am J Physiol Renal Physiol 2007, 292: F1105-F11223.CrossRefPubMed
18.
go back to reference Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000, 11: 97-104.PubMed Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000, 11: 97-104.PubMed
19.
go back to reference Jones D, Bellomo R: Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition? J Intensive Care Med 2005, 20: 199-211. 10.1177/0885066605276963CrossRefPubMed Jones D, Bellomo R: Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition? J Intensive Care Med 2005, 20: 199-211. 10.1177/0885066605276963CrossRefPubMed
20.
go back to reference Marik PE: Low-dose dopamine: a systematic review. Intensive Care Med 2002, 28: 877-883. 10.1007/s00134-002-1346-yCrossRefPubMed Marik PE: Low-dose dopamine: a systematic review. Intensive Care Med 2002, 28: 877-883. 10.1007/s00134-002-1346-yCrossRefPubMed
21.
go back to reference Woo EB, Tang AT, el-Gamel A, Green halgh D, Patrick M, Jones MT, Hooper TL: Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg 2002, 22: 106-111. 10.1016/S1010-7940(02)00246-4CrossRefPubMed Woo EB, Tang AT, el-Gamel A, Green halgh D, Patrick M, Jones MT, Hooper TL: Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg 2002, 22: 106-111. 10.1016/S1010-7940(02)00246-4CrossRefPubMed
22.
go back to reference Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J: Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356: 2139-2143.CrossRefPubMed Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J: Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356: 2139-2143.CrossRefPubMed
23.
go back to reference Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten SE: Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients. Acta Anaesthesiol Scand 2010, 54: 183-190. 10.1111/j.1399-6576.2009.02121.xCrossRefPubMed Redfors B, Bragadottir G, Sellgren J, Swärd K, Ricksten SE: Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients. Acta Anaesthesiol Scand 2010, 54: 183-190. 10.1111/j.1399-6576.2009.02121.xCrossRefPubMed
24.
go back to reference Edwards RM: Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro. Eur J Pharmacol 1986, 126: 167-170. 10.1016/0014-2999(86)90756-9CrossRefPubMed Edwards RM: Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro. Eur J Pharmacol 1986, 126: 167-170. 10.1016/0014-2999(86)90756-9CrossRefPubMed
25.
go back to reference Mathur VS, Swan SK, Anjum S, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epsein M, Luther RR: The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999, 27: 1832-1837. 10.1097/00003246-199909000-00021CrossRefPubMed Mathur VS, Swan SK, Anjum S, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epsein M, Luther RR: The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999, 27: 1832-1837. 10.1097/00003246-199909000-00021CrossRefPubMed
26.
go back to reference Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD: The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002, 19: 32-39.CrossRefPubMed Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD: The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002, 19: 32-39.CrossRefPubMed
27.
go back to reference Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G, Guelfi P: Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 2007, 21: 847-850. 10.1053/j.jvca.2007.02.022CrossRefPubMed Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G, Guelfi P: Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 2007, 21: 847-850. 10.1053/j.jvca.2007.02.022CrossRefPubMed
28.
go back to reference Bove T, Landoni G, Calabrò MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A: Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005, 111: 3230-3235. 10.1161/CIRCULATIONAHA.104.509141CrossRefPubMed Bove T, Landoni G, Calabrò MG, Aletti G, Marino G, Cerchierini E, Crescenzi G, Zangrillo A: Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 2005, 111: 3230-3235. 10.1161/CIRCULATIONAHA.104.509141CrossRefPubMed
29.
go back to reference Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT: Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998, 128: 194-203.CrossRefPubMed Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT: Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998, 128: 194-203.CrossRefPubMed
30.
go back to reference Englberger L, Suri RM, Li Z, Casey ET, Daily RC, Dearani HA, Schaff HV: Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011, 15: R16. 10.1186/cc9960PubMedCentralCrossRefPubMed Englberger L, Suri RM, Li Z, Casey ET, Daily RC, Dearani HA, Schaff HV: Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011, 15: R16. 10.1186/cc9960PubMedCentralCrossRefPubMed
31.
go back to reference Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004, 15: 1597-1605. 10.1097/01.ASN.0000130340.93930.DDCrossRefPubMed Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004, 15: 1597-1605. 10.1097/01.ASN.0000130340.93930.DDCrossRefPubMed
32.
go back to reference Kanji HD, Schulze CJ, Hervas-Malo M, Wang P, Ross DB, Zibdawi M, Bagshaw SM: Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg 2010, 5: 71. 10.1186/1749-8090-5-71PubMedCentralCrossRefPubMed Kanji HD, Schulze CJ, Hervas-Malo M, Wang P, Ross DB, Zibdawi M, Bagshaw SM: Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury. J Cardiothorac Surg 2010, 5: 71. 10.1186/1749-8090-5-71PubMedCentralCrossRefPubMed
33.
go back to reference Thurau K, Boylan JW: Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med 1976, 61: 308-315. 10.1016/0002-9343(76)90365-XCrossRefPubMed Thurau K, Boylan JW: Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med 1976, 61: 308-315. 10.1016/0002-9343(76)90365-XCrossRefPubMed
34.
go back to reference Rosenberger C, Rosen S, Heyman SN: Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006, 33: 980-988. 10.1111/j.1440-1681.2006.04472.xCrossRefPubMed Rosenberger C, Rosen S, Heyman SN: Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006, 33: 980-988. 10.1111/j.1440-1681.2006.04472.xCrossRefPubMed
35.
go back to reference Molitoris BA, Falk SA, Dahl RH: Ischemia-induced loss of epithelial polarity. Role of the tight junction. J Clin Invest 1989, 84: 1334-1339. 10.1172/JCI114302PubMedCentralCrossRefPubMed Molitoris BA, Falk SA, Dahl RH: Ischemia-induced loss of epithelial polarity. Role of the tight junction. J Clin Invest 1989, 84: 1334-1339. 10.1172/JCI114302PubMedCentralCrossRefPubMed
36.
go back to reference Molitoris BA: Na(+)-K(+)-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am J Physiol 1993, 265: F693-697.PubMed Molitoris BA: Na(+)-K(+)-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am J Physiol 1993, 265: F693-697.PubMed
37.
go back to reference Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjetti A, Hintze TH: Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 1998, 82: 1263-1271. 10.1161/01.RES.82.12.1263CrossRefPubMed Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjetti A, Hintze TH: Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 1998, 82: 1263-1271. 10.1161/01.RES.82.12.1263CrossRefPubMed
38.
go back to reference Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH: Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994, 345: 50-54. 10.1016/0014-5793(94)00424-2CrossRefPubMed Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH: Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994, 345: 50-54. 10.1016/0014-5793(94)00424-2CrossRefPubMed
39.
go back to reference Valsson F, Ricksten SE, Hedner T, Lundin S: Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996, 22: 230-236. 10.1007/BF01712242CrossRefPubMed Valsson F, Ricksten SE, Hedner T, Lundin S: Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996, 22: 230-236. 10.1007/BF01712242CrossRefPubMed
40.
go back to reference Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004, 32: 1310-1315. 10.1097/01.CCM.0000128560.57111.CDCrossRefPubMed Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE: Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004, 32: 1310-1315. 10.1097/01.CCM.0000128560.57111.CDCrossRefPubMed
41.
go back to reference Burke TJ, Cronin RE, Duchin KL, Peterson LN, Schrier RW: Ischemia and tubule obstruction during acute renal failure in dogs: mannitol in protection. Am J Physiol 1980, 238: F305-F314.PubMed Burke TJ, Cronin RE, Duchin KL, Peterson LN, Schrier RW: Ischemia and tubule obstruction during acute renal failure in dogs: mannitol in protection. Am J Physiol 1980, 238: F305-F314.PubMed
42.
go back to reference Valdes ME, Landau SE, Shah DM, Newell JC, Scovill WA, Stratton H, Rhodes GR, Powers SR Jr: Increased glomerular filtration rate following mannitol administration in man. J Surg Res 1979, 26: 473-477. 10.1016/0022-4804(79)90036-2CrossRefPubMed Valdes ME, Landau SE, Shah DM, Newell JC, Scovill WA, Stratton H, Rhodes GR, Powers SR Jr: Increased glomerular filtration rate following mannitol administration in man. J Surg Res 1979, 26: 473-477. 10.1016/0022-4804(79)90036-2CrossRefPubMed
43.
go back to reference Molitoris BA, Sandoval R, Sutton TA: Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med 2002, 30: S235-S240. 10.1097/00003246-200205001-00011CrossRefPubMed Molitoris BA, Sandoval R, Sutton TA: Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med 2002, 30: S235-S240. 10.1097/00003246-200205001-00011CrossRefPubMed
44.
go back to reference Bragadottir G, Redfors B, Ricksten SE: Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury - a prospective interventional study. Crit Care 2012, 16: R159. 10.1186/cc11480PubMedCentralCrossRefPubMed Bragadottir G, Redfors B, Ricksten SE: Mannitol increases renal blood flow and maintains filtration fraction and oxygenation in postoperative acute kidney injury - a prospective interventional study. Crit Care 2012, 16: R159. 10.1186/cc11480PubMedCentralCrossRefPubMed
45.
go back to reference Kristof AS, Magder S: Low systemic vascular resistance in patients undergoing cardiopulmonary bypass. Crit Care Med 1999, 27: 1121-1127. 10.1097/00003246-199906000-00033CrossRefPubMed Kristof AS, Magder S: Low systemic vascular resistance in patients undergoing cardiopulmonary bypass. Crit Care Med 1999, 27: 1121-1127. 10.1097/00003246-199906000-00033CrossRefPubMed
46.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008, 34: 17-60. 10.1007/s00134-007-0934-2PubMedCentralCrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008, 34: 17-60. 10.1007/s00134-007-0934-2PubMedCentralCrossRefPubMed
47.
go back to reference Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE: Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 2011, 37: 60-67. 10.1007/s00134-010-2057-4CrossRefPubMed Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE: Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 2011, 37: 60-67. 10.1007/s00134-010-2057-4CrossRefPubMed
48.
go back to reference Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345: 588-595. 10.1056/NEJMra002709CrossRefPubMed Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345: 588-595. 10.1056/NEJMra002709CrossRefPubMed
49.
go back to reference Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997, 25: 1279-1282. 10.1097/00003246-199708000-00012CrossRefPubMed Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997, 25: 1279-1282. 10.1097/00003246-199708000-00012CrossRefPubMed
50.
go back to reference Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96: 576-582. 10.1097/00000542-200203000-00011CrossRefPubMed Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96: 576-582. 10.1097/00000542-200203000-00011CrossRefPubMed
51.
go back to reference ter Wee PM, Smit AJ, Rosman JB, Sluiter WJ, Donker AJ: Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 1986, 6: 42-46. 10.1159/000167051CrossRefPubMed ter Wee PM, Smit AJ, Rosman JB, Sluiter WJ, Donker AJ: Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 1986, 6: 42-46. 10.1159/000167051CrossRefPubMed
52.
go back to reference Schoors DF, Dupont AG: Further studies on the mechanism of the natriuretic response to low-dose dopamine in man: effect on lithium clearance and nephrogenic cAMP formation. Eur J Clin Invest 1990, 20: 385-391.CrossRefPubMed Schoors DF, Dupont AG: Further studies on the mechanism of the natriuretic response to low-dose dopamine in man: effect on lithium clearance and nephrogenic cAMP formation. Eur J Clin Invest 1990, 20: 385-391.CrossRefPubMed
53.
go back to reference Olsen NV, Lund J, Jensen PF, Espersen K, Kanstrup IL, Plum I, Leyssac PP: Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993, 79: 685-594. 10.1097/00000542-199310000-00009CrossRefPubMed Olsen NV, Lund J, Jensen PF, Espersen K, Kanstrup IL, Plum I, Leyssac PP: Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993, 79: 685-594. 10.1097/00000542-199310000-00009CrossRefPubMed
54.
go back to reference Olsen NV, Hansen JM, Kanstrup IL, Richalet JP, Leyssac PP: Renal hemodynamics, tubular function, and response to low-dose dopamine during acute hypoxia in humans. J Appl Physiol 1993, 74: 2166-2173.PubMed Olsen NV, Hansen JM, Kanstrup IL, Richalet JP, Leyssac PP: Renal hemodynamics, tubular function, and response to low-dose dopamine during acute hypoxia in humans. J Appl Physiol 1993, 74: 2166-2173.PubMed
55.
go back to reference Olsen NV, Lang-Jensen T, Hansen JM, Plum I, Thomsen JK, Strangaard S, Leyssac PP: Effects of acute beta-adrenoceptor blockade with metoprolol on the renal response to dopamine in normal humans. Br J Clin Pharmacol 1994, 37: 347-353. 10.1111/j.1365-2125.1994.tb04288.xPubMedCentralCrossRefPubMed Olsen NV, Lang-Jensen T, Hansen JM, Plum I, Thomsen JK, Strangaard S, Leyssac PP: Effects of acute beta-adrenoceptor blockade with metoprolol on the renal response to dopamine in normal humans. Br J Clin Pharmacol 1994, 37: 347-353. 10.1111/j.1365-2125.1994.tb04288.xPubMedCentralCrossRefPubMed
56.
go back to reference Richer M, Robert S, Lebel M: Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 1996, 24: 1150-1156. 10.1097/00003246-199607000-00014CrossRefPubMed Richer M, Robert S, Lebel M: Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 1996, 24: 1150-1156. 10.1097/00003246-199607000-00014CrossRefPubMed
57.
go back to reference Mc Donald RH, Goldberg LI, McNay JL, Tuttle EP: Effect of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 1964, 43: 1116-1124. 10.1172/JCI104996CrossRef Mc Donald RH, Goldberg LI, McNay JL, Tuttle EP: Effect of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 1964, 43: 1116-1124. 10.1172/JCI104996CrossRef
58.
go back to reference Rosenblum R, Tai AR, Lawson D: Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease. J Pharmacol Exp Ther 1972, 183: 256-263.PubMed Rosenblum R, Tai AR, Lawson D: Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease. J Pharmacol Exp Ther 1972, 183: 256-263.PubMed
59.
go back to reference Schwartz LB, Bissell MG, Murphy M, Gewertz BL: Renal effects of dopamine in vascular surgical patients. J Vasc Surg 1988, 8: 367-374.CrossRefPubMed Schwartz LB, Bissell MG, Murphy M, Gewertz BL: Renal effects of dopamine in vascular surgical patients. J Vasc Surg 1988, 8: 367-374.CrossRefPubMed
60.
go back to reference Graves TA, Cioffi WG, Vaughan GM, Pratt L, Heironimus JD, McManus WF, Pruitt BA Jr: The renal effects of low-dose dopamine in thermally injured patients. J Trauma 1993, 35: 97-102. 10.1097/00005373-199307000-00016CrossRefPubMed Graves TA, Cioffi WG, Vaughan GM, Pratt L, Heironimus JD, McManus WF, Pruitt BA Jr: The renal effects of low-dose dopamine in thermally injured patients. J Trauma 1993, 35: 97-102. 10.1097/00005373-199307000-00016CrossRefPubMed
61.
go back to reference Ungar A, Fumagalli S, Marini M, Di Serio C, Taranti F, Boncinelli G, Valoti P, La Cava G, Oliani C, Masotti G, Marchionni N: Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med 2004, 32: 1125-1129. 10.1097/01.CCM.0000124871.58281.D1CrossRefPubMed Ungar A, Fumagalli S, Marini M, Di Serio C, Taranti F, Boncinelli G, Valoti P, La Cava G, Oliani C, Masotti G, Marchionni N: Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med 2004, 32: 1125-1129. 10.1097/01.CCM.0000124871.58281.D1CrossRefPubMed
Metadata
Title
Renal oxygenation in clinical acute kidney injury
Authors
Sven-Erik Ricksten
Gudrun Bragadottir
Bengt Redfors
Publication date
01-04-2013
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc12530

Other articles of this Issue 2/2013

Critical Care 2/2013 Go to the issue